The incidence of collagen-associated adverse events in pediatric population with the use of Fluoroquinolones: a nationwide cohort study in Taiwan
Authors:
Preprint
- 6 February 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: To evaluate the safety of using fluoroquinolones in pediatric population in Taiwan. Methods : Patients aged 0~18 years old with fluoroquinolones prescriptions ≥5 consecutive days during year 2000 to 2013 were selected from the National Health Insurance Research Database, 4-time case number were selected as controls. We evaluated the patient’s outcome after the use of fluoroquinolones by reviewing a newly diagnosis of the following collagen-associated adverse events by International Classification of Diseases, Ninth Revision, Clinical Modification codes, covering tendons rupture, retinal detachments, gastrointestinal tract perforation, aortic aneurysm or dissection. Results : Of the enrolled patients (n=167,105), collagen-associated adverse effects developed in 85 cases (0.051%) in 6-month tracking, including 0.051% in the fluoroquinolones study cohort (17 in 33,421) and 0.051% (68 in 133,684) in the fluoroquinolones free comparison cohort. The crude hazard ratio for collagen-associated adverse events in the fluoroquinolones group was 0.997 (0.586-1.696; p=0.990). After adjusting for age, sex, catastrophic illness, low-income household, seasons, levels of urbanization, and healthcare, the corrected hazard ratio in 6-month tracking with FQs was 1.330 (95% CI; 0.778-2.276; p=0.255). Conclusions: There is no significant difference of collagen-associated adverse effects between fluoroquinolones group and fluoroquinolones free group from our data. We propose that fluoroquinolones for pediatric population in clinical practice may be not so harmful as previous references reported.Keywords
All Related Versions
- Published version: BMC Pediatrics, 20 (1), 1.
This publication has 29 references indexed in Scilit:
- High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in TaiwanJournal of Microbiology, Immunology and Infection, 2016
- Safety Concerns Surrounding Quinolone Use in ChildrenThe Journal of Clinical Pharmacology, 2016
- Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral FluoroquinoloneJAMA Internal Medicine, 2015
- Use of administrative data in healthcare researchInternal and Emergency Medicine, 2015
- Tendon Injury and Fluoroquinolone Use: A Systematic ReviewDrug Safety, 2013
- Oral Fluoroquinolones and the Risk of Retinal DetachmentJAMA, 2012
- Peripheral Arterial Disease in Patients With DiabetesJACC, 2006
- Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cellsToxicology, 2005
- Clinical and Genetic Features of Vascular Ehlers-Danlos SyndromeAnnals of Vascular Surgery, 2002
- Colon perforation in Ehlers-Danlos syndromeThe American Journal of Surgery, 1984